A systematic review of moral reasons on orphan drug reimbursement
Abstract Background The number of market approvals of orphan medicinal products (OMPs) has been increasing steadily in the last 3 decades. While OMPs can offer a unique chance for patients suffering from rare diseases, they are usually very expensive. The growing number of approved OMPs increases th...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2021-06-01
|
| Edice: | Orphanet Journal of Rare Diseases |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13023-021-01925-y |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|